(Q40165649)

18 September 2017

1 reference

title

Nobel lecture, 8th December 1982. Adventures and excursions in bioassay: the stepping stones to prostacyclin (English)

1 reference

18 September 2017

1

Vane JR

1 reference

PMC publication ID

2044916

18 September 2017

language of work or name

English

0 references

publication date

1 August 1983

1 reference

British Journal of Pharmacology

18 September 2017

1 reference

18 September 2017

79

1 reference

18 September 2017

4

1 reference

18 September 2017

821-838

1 reference

The technique of superfusion

18 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2044916

Eighth Gaddum Memorial Lecture. University of London Institute of Education, December 1980. Biological importance of prostacyclin

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2044916

Diet-induced hypercholesterolemia inhibits the recovery of prostacyclin production by injured rabbit aorta

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2044916

The effects of prostacyclin (PGI2) on endotoxin shock and endotoxin-induced platelet aggregation in dogs.

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2044916

Preliminary experience with prostaglandins E1 and I2 in peripheral vascular disease.

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2044916

Role of prostaglandins in the defense of the gastric mucosa

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2044916

Prostacyclin: a hormone with a therapeutic potential. The Sir Henry Dale Lecture for 1981.

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2044916

Role of Ca2+ and cyclic AMP in the regulation of the production of prostacyclin by the vascular endothelium

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2044916

Regulation of endothelial cell cyclic nucleotide metabolism by prostacyclin

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2044916

Prostacyclin administration during cardiopulmonary bypass in man.

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2044916

The disappearance of bradykinin and eledoisin in the circulation and vascular beds of the cat

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2044916

Indomethacin and aspirin abolish prostaglandin release from the spleen

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2044916

Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2044916

The release and fate of vaso-active hormones in the circulation

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2044916

The detection and estimation of bradykinin in the circulating blood

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2044916

The release of catechol amines from the adrenal medulla by histamine

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2044916

Pharmacokinetic function of the pulmonary circulation

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2044916

Fate of angiotensin I in the circulation

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2044916

Conversion of angiotensin I to angiotensin II.

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2044916

Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2044916

The effects of prostagladin endoperoxides and thromboxane A2 on strips of rabbit coeliac artery and certain other smooth muscle preparations [proceedings]

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2044916

Arterial walls are protected against deposition of platelet thrombi by a substance (prostaglandin X) which they make from prostaglandin endoperoxides

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2044916

An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2044916

Recirculation of prostacyclin (PGI2) in the dog

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2044916

Cardiac and renal prostaglandin I2. Biosynthesis and biological effects in isolated perfused rabbit tissues

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2044916

Synthesis of prostaglandin I2 (prostacyclin) by cultured human and bovine endothelial cells

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2044916

Cyclic adenosine 3′,5′-monophosphate and prostacyclin inhibit membrane phospholipase activity in platelets

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2044916

Stimulation of calcium uptake in platelet membrane vesicles by adenosine 3′,5′-cyclic monophosphate and protein kinase

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2044916

Effects of prostacyclin (PGX) on cyclic AMP concentrations in human platelets

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2044916

Modulation of human platelet adenylate cyclase by prostacyclin (PGX)

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2044916

Cyclic adenosine 3',5'-monophosphate inhibits the availability of arachidonate to prostaglandin synthetase in human platelet suspensions

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2044916

Cyclic AMP inhibits synthesis of prostaglandin endoperoxide (PGG2) in human platelets

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2044916

Pharmacology and endogenous roles of prostaglandin endoperoxides, thromboxane A2, and prostacyclin

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2044916

Prevention of blockage of partially obstructed coronary arteries with prostacyclin correlates with inhibition of platelet aggregation

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2044916

Metabolism of prostacyclin. Oxidation by rhesus monkey lung 15-hydroxyl prostaglandin dehydrogenase

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2044916

Successful therapy of advanced arteriosclerosis obliterans with prostacyclin

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2044916

Human arterial and venous tissues generate prostacyclin (prostaglandin x), a potent inhibitor of platelet aggregation

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2044916

The chemical structure of prostaglandin X (prostacyclin)

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2044916

Effect of pyrogen and antipyretics on prostaglandin acitvity in cisternal c.s.f. of unanaesthetized cats

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2044916

Effect of prostacyclin (PGI2) on platelet adhesion to rabbit arterial subendothelium

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2044916

Circulatory and anti-platelet effects of intravenous prostacyclin in healthy men

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2044916

Prostacyclin reduces the number of 'slow moving' leucocytes in hamster cheek pouch venules [proceedings]

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2044916

Generation of prostacyclin by lungs in vivo and its release into the arterial circulation

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2044916

Localisation and stimulation of prostacyclin production in vascular cells

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2044916

Differential formation of prostacyclin (PGX or PGI2) by layers of the arterial wall. An explanation for the anti-thrombotic properties of vascular endothelium

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2044916

Topical prostacyclin (PGI2) inhibits platelet aggregation in pial venules of the mouse

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2044916

The inactivation of noradrenaline and isoprenaline in dogs

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2044916

Further studies on the enzymatic conversion of prostaglandin endoperoxide into prostacyclin by porcine aorta microsomes

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2044916

Prostacyclin in experimental myocardial ischemia: effects on hemodynamics, regional myocardial blood flow, infarct size and mortality

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2044916

Salutary effects of prostacyclin in endotoxic shock

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2044916

Treatment of pulmonary embolism with prostacyclin.

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2044916

Earlier charcoal haemoperfusion in fulminant hepatic failure

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2044916

Prostacyclin: haemodynamic and metabolic effects in patients with coronary artery disease

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2044916

Inactivation of Prostaglandins by the Lungs

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2044916

The occurrence of prostaglandin E2 in splenic venous blood of the dog following splenic nerve stimulation

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2044916

Release of additional factors in anaphylaxis and its antagonism by anti-inflammatory drugs

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2044916

Release of catecholamines in the guinea-pig by substances involved in anaphylaxis.

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2044916

Contribution of intrarenal generation of prostaglandin to autoregulation of renal blood flow in the dog.

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2044916

Release of rabbit aorta contracting substance (RCS) and prostaglandins induced by chemical or mechanical stimulation of guinea-pig lungs

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2044916

Mediators of the anaphylactic reaction

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2044916

The release of prostaglandins from lung and other tissues

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2044916

Prostaglandin Endoperoxides IX. Characterization of Rabbit Aorta Contracting Substance (RCS) from Guinea Pig Lung and Human Platelets

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2044916

A laminar flow superfusion technique with much increased sensitivity for the detection of smooth muscle-stimulating substances

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2044916

Identification of an enzyme in platelet microsomes which generates thromboxane A2 from prostaglandin endoperoxides

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2044916

Studies on the protective effect of prostacyclin in acute myocardial ischemia

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2044916

Effects of intravenous prostacyclin in variant angina.

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2044916

Clinical use of prostacyclin (PGI2) in ischaemic stroke.

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2044916

The release of catecholamines from the adrenal medulla by peptides

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2044916

Disappearance of angiotensin from the circulation of the dog.

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2044916

John Henry Gaddum. 1900-1965

20 August 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1476-5381.1983.TB10020.X

Release of noradrenaline from sympathetic endings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1476-5381.1983.TB10020.X

Anti-aggregatory effect of prostacyclin (PGI2) in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1476-5381.1983.TB10020.X

Changes in pigeon cone photocurrent caused by reduction in extracellular calcium activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1476-5381.1983.TB10020.X

Prostaglandins: Their Disappearance from and Release into the Circulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1476-5381.1983.TB10020.X

Disappearance of Catecholamines from the Circulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1476-5381.1983.TB10020.X

Selective Passage of Prostaglandins across the Lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1476-5381.1983.TB10020.X

Vasoconstriction with thromboxane A2 induces ulceration of the gastric mucosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1476-5381.1983.TB10020.X

The effect of infused prostacyclin in migraine and cluster headache

21 January 2018

1 reference

12 December 2020

Treatment of intermittent claudication. A reappraisal of the value of alpha-tocopherol

1 reference

12 December 2020

Prostacyclin therapy in patients with congestive heart failure

1 reference

12 December 2020

Inhibition of polymorphonuclear leukocyte adherence by prostacyclin

1 reference

12 December 2020

Studies on the role of lipoperoxides in human pathology. II. The presence of peroxidized lipids in the atherosclerotic aorta

1 reference

12 December 2020

Prostacyclin prolongs viability of washed human platelets

1 reference

12 December 2020

Prostacyclin production by isolated adipocytes

1 reference

12 December 2020

Release of prostaglandins from embolized lungs

1 reference

12 December 2020

The estimation of catecholamines by biological assay

1 reference

12 December 2020

Arterial walls generate from prostaglandin endoperoxides a substance (prostaglandin X) which relaxes strips of mesenteric and coeliac ateries and inhibits platelet aggregation

1 reference

12 December 2020

Successful treatment of Raynaud's Syndrome with prostacyclin

1 reference

12 December 2020

Treatment of pregnancy hypertension with prostacyclin

1 reference

12 December 2020

The treatment of peripheral occlusive arterial disease with alpha-tocopherol as compared with vasodilator agents and antiprothrombin (dicumarol)

1 reference

12 December 2020

The effect of prostacyclin infusion on endotoxin-induced lung injury

1 reference

12 December 2020

Effects of prostacyclin during cardiopulmonary bypass in man

1 reference

12 December 2020

Beneficial effects of a new carbacyclin derivative, ZK 36 374, in acute myocardial ischemia

1 reference

12 December 2020

Aspirin selectively inhibits prostaglandin production in human platelets

1 reference

12 December 2020

Prostacyclin therapy of thrombotic thrombocytopenic purpura

1 reference

12 December 2020

Defective fibrinolytic and prostacyclin-like activity in human atheromatous plaques

1 reference

12 December 2020

Endothelial cell adenylate cyclase: activation by catecholamines and prostaglandin I2+

1 reference

12 December 2020

Use of prostacyclin in persistent fetal circulation

1 reference

12 December 2020

Bioassay of prostaglandins and biologically active substances derived from arachidonic acid

1 reference

12 December 2020

Prostacyclin-induced acute pulmonary vasodilation in primary pulmonary hypertension

1 reference

12 December 2020

Prostacyclin generation in atherosclerotic arteries

1 reference

12 December 2020

Prostacyclin: a potent antimetastatic agent

1 reference

12 December 2020

INTERMITTENT EPOPROSTENOL (PROSTACYCLIN) INFUSION IN PATIENTS WITH RAYNAUD'S SYNDROME

1 reference

12 December 2020

Short term suppression of hyperacute renal allograft rejection in presensitised dogs with prostacyclin

1 reference

12 December 2020

Dependency of Renal Blood Flow on Prostaglandin Synthesis in the Dog

1 reference

12 December 2020

Twenty-four- and 48-hour canine liver preservation by simple hypothermia with prostacyclin

1 reference

12 December 2020

Clinical potential of prostacyclin

1 reference

12 December 2020

The continuous estimation of angiotensin formed in the circulation of the dog

1 reference

12 December 2020

Prevention of infarction-induced decrease in circulating platelet count by prostacyclin

1 reference

12 December 2020

On the nature of inhibition in the intestine

1 reference

12 December 2020

Prostacyclin for pulmonary hypertension

1 reference

12 December 2020

Prostaglandin endoperoxide and thromboxane generating systems and their selective inhibition

1 reference

12 December 2020

A lipid peroxide inhibits the enzyme in blood vessel microsomes that generates from prostaglandin endoperoxides the substance (prostaglandin X) which prevents platelet aggregation

1 reference

12 December 2020

Administration of prostacyclin prevents ventricular fibrillation following coronary occlusion in conscious dogs

1 reference

12 December 2020

Prostacyclin deficiency in thrombotic thrombocytopenic purpura

1 reference

12 December 2020

Differential inhibition by prostaglandins of the renal actions of pressor stimuli

1 reference

12 December 2020

The effect of prostacyclin (PGT2) on platelet behaviour. Thrombus formation in vivo and bleeding time

1 reference

12 December 2020

The effects of alteration of blood-volume on the concentration of circulating angiotensin in anaesthetized dogs

1 reference

12 December 2020

Treatment of chronic kidney transplant rejection with prostacyclin - reduction of platelet deposition in the transplant; prolongation of platelet survival and improvement of transplant function

1 reference

12 December 2020

EPOPROSTENOL (PROSTACYCLIN) AND SEVERE ARTERIAL DISEASE

1 reference

12 December 2020

PROSTAGLANDINS AND RELATED FACTORS. 28. METABOLISM OF PROSTAGLANDIN E1 IN GUINEA PIG LUNG: THE STRUCTURES OF TWO METABOLITES

1 reference

12 December 2020

Safety of coronary arterial prostacyclin infusion

1 reference

12 December 2020

The Generation of Kinins in the Blood of Dogs during Hypotension Due to Haemorrhage

1 reference

12 December 2020

Parallel assay of prostaglandin-like activity in rat inflammatory exudate by means of cascade superfusion

1 reference

12 December 2020

Prostacyclin to prevent platelet activation during charcoal haemoperfusion in fulminant hepatic failure

1 reference

12 December 2020

Prostacyclin in central retinal vein occlusion

1 reference

12 December 2020

Intravenous prostacyclin for ischemic ulcers in peripheral artery disease

1 reference

12 December 2020

Prostacyclin and prostaglandin E1 for severe idiopathic pulmonary artery hypertension

1 reference

12 December 2020

Measurement of epinephrine, norepinephrine and related compounds; bioassay procedures

1 reference

12 December 2020

10.1111/J.1476-5381.1983.TB10020.X

Identifiers

DOI

1 reference

18 September 2017

1 reference

PMC publication ID

2044916

18 September 2017

PubMed publication ID

6360277

1 reference

PMC publication ID

2044916